← Eichor
Study identifier: NCT06494683 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus

Condition: Type 2 Diabetes Mellitus  ·  Sponsor: Jiangxi University of Traditional Chinese Medicine

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

As a dietary herb, pueraria lobata radix (PLR) has been showed to have hypoglycemic effects in animal experiments. However, there is currently a lack of evidence from randomized controlled trials. Therefore, this randomized, double-blind, placebo-controlled trial aims to assess the efficacy and safety of PLR as an adjunctive treatment for type 2 diabetes mellitus (T2DM).

This description comes directly from the study's public registry record.

Talk to the study team

Xu Zhou, M.D  ·  +8618870050733  ·  zhouxu_ebm@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (2)

The First Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, ChinaNot Yet Recruiting
The Affiliated Hospital of Jiangxi University of Traditional Chinese MedicineNanchang, Jiangxi, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06494683